KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Twist Bioscience (TWST) Other Operating Expenses: 2018-2025

Historic Other Operating Expenses for Twist Bioscience (TWST) over the last 8 years, with Sep 2025 value amounting to $48.2 million.

  • Twist Bioscience's Other Operating Expenses rose 3.65% to $48.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $189.7 million, marking a year-over-year decrease of 15.54%. This contributed to the annual value of $48.8 million for FY2025, which is 78.25% down from last year.
  • As of Q3 2025, Twist Bioscience's Other Operating Expenses stood at $48.2 million, which was down 1.38% from $48.8 million recorded in Q2 2025.
  • In the past 5 years, Twist Bioscience's Other Operating Expenses ranged from a high of $91.1 million in Q2 2024 and a low of -$1.9 million during Q2 2021.
  • Over the past 3 years, Twist Bioscience's median Other Operating Expenses value was $45.9 million (recorded in 2023), while the average stood at $42.0 million.
  • In the last 5 years, Twist Bioscience's Other Operating Expenses crashed by 97.92% in 2021 and then soared by 15,583.82% in 2024.
  • Over the past 5 years, Twist Bioscience's Other Operating Expenses (Quarterly) stood at $2.8 million in 2021, then spiked by 46.32% to $4.1 million in 2022, then spiked by 928.68% to $42.5 million in 2023, then increased by 7.85% to $45.9 million in 2024, then grew by 3.65% to $48.2 million in 2025.
  • Its Other Operating Expenses stands at $48.2 million for Q3 2025, versus $48.8 million for Q2 2025 and $46.8 million for Q1 2025.